DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR THE ESTIMATION OF A COMBINATION OF PRAVASTATIN SODIUM AND VALSARTAN BY REVERSED PHASE-HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
Abstract
ABSTRACT
Objective: The main aim of this study was to develop and validate analytical methods for an estimation of a combination of two different drugs by
high performance liquid chromatography (HPLC). The objective of this study was to demonstrate that the method is suitable for its intended purpose
as it is stated in ICH guidelines. The method was validated for linearity, precision, accuracy, specificity, and limit of detection, limit of quantification,
and robustness.
Methods: Various parameters were analyzed for a drug combination according to standard procedures. The aim of this study was to develop a simple,
accurate, and precise HPLC method for the analysis of the combination of pravastatin sodium (PVS) and valsartan using mobile phase and commonly
employed Nucleodur C
column with ultraviolet detector at 238 nm. The typical chromatogram of PVS and valsartan was shown in Fig. 5. The optimal
retention time was found to be 4.815 minutes for PVS and 15.518 minutes for valsartan.
18
Result: The result of linearity for both PVS and valsartan was given in Tables 1 and 2, respectively. The results are shown in Tables 3 and 4. The
repeatability refers to the use of the analytical procedure within a laboratory over a short period of time using the same analyst with the same
equipment and is expressed as the % relative standard deviation (RSD). The results of method precision are shown in Table 4. The % RSD for method
precision was found to be 0.79 for PVS and 0.32 for valsartan. The results are shown in Tables 5 and 6. The ruggedness of analytical method is the
degree of reproducibility of the test results obtained by the same samples under a variety of conditions such as different laboratories, different
analysts, different instruments, different lots of reagents, and different days. The assay result indicated that the method was capable with a high
precision. The results of % RSD prove the ruggedness of developed method as shown in Tables 7 and 8.
Conclusion: The proposed reversed phase-HPLC method enables the determination of PVS and valsartan because of a good separation of
chromatographic peaks (Fig. 5). The method can be used successfully for the analysis of PVS and valsartan in combination.
Keywords: Pravastatin sodium, Valsartan, High performance liquid chromatography, Validation.
Downloads
References
REFERENCES
Rang HP, Dale MM, Ritter JN, Flower RJ. Rang and Dale’s
Pharmacology. 6
ed. Edinburgh: Churchill Livingstone, Elsevier
Science Ltd.; 2003.
th
Table 14B: Data derived from robustness experiment for valsartan: Change in wavelength
S. No. Concentrated
(µg/ml)
Mahley RW, Bersot TP. Drug therapy for hyper-cholesterolemia and
dyslipidemia. In: Hardman JG, Limberd LE, editors. Goodman and
Gilman’s The Pharmacological Basis of Therapeutics. New York: TheMcGraw Hill, Medical Publishing Division; 2007. p. 984-9.
O’ Neil MJ, Smith A, Heckelman PE, Kinneary JF. The Merck Index:
An Encyclopedia of Chemicals, Drugs and Biologicals. 14
ed.
New York: Wiley; 2006. p. 1767.
Sweetman SC. Matrindale: The Complete Drug Reference. 34
ed.
London, Chicago: Pharmaceutical Press; 2002. p. 1018.
Koh KK, Lim S, Choi H, Lee Y, Han SH, Lee K, et al. Combination
pravastatin and valsartan treatment has additive beneficial effects to
simultaneously improve both metabolic and cardiovascular phenotypes
beyond that of monotherapy with either drug in patients with primary
hypercholesterolemia. Diabetes 2013;62(10):3547-52.
ICH. Q2B. Validation of Analytical Procedures Methodology. In:
Proceedings of the International Conference on Harmonization.
Geneva; 1993.
Sethi PD. HPLC Quantitative Analysis of Pharmaceutical Formulations.
ed. New Delhi: CBS Publishers and Distributors; 2001. p. 11-160.
Krull I, Swartz M. Validation viewpoint, introduction: National and
st
International Guidelines. LC-GC 1997;15(6):534-39.
United States Pharmacopoeia. Validation of Compendial Methods.
Rockville, MD: United States Pharmacopoeia Convention; 2007.
Astm E. Standard Guide for Conducting Ruggedness Tests (Plackett-
Burman Design). ???: ???; ???. p. 1169-89.
Plackett RL, Burman JP. Biometrika. 33
ed. ???: ???; 1943. p. 3052511.
.
rd
th
th
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.